Melanoma: open trials in Austria

10 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Medizinische Universitaet Innsbruck, Innsbruck
Registry updated 2026-11-03
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Medical University of Graz, Graz
Registry updated 2026-10-06
2026-526261-14-00
PHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure
Trial Treatment · Phase 2 · Therakos Europe Limited
Medical University of Graz, Graz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna
Registry updated 2026-10-05
NCT07338968
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Research · Phase 3 · Aura Biosciences
Medical University of Graz, Graz
Registry updated 2026-08-19
NCT07635732
Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy
Research · Medical University of Graz
Department of Dermatology and Venereology, Medical University of Graz, Gratwein
Registry updated 2026-06-09
NCT07015190
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Trial Treatment · Phase 3 · IDEAYA Biosciences
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Medical University of Vienna, Vienna
Registry updated 2026-05-06
NCT05549297
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Trial Treatment · Phase 3 · Immunocore Ltd
Medical University of Graz, Graz · Johannes Kepler University, Linz · SCRI CCCIT Ges.m.b.H., Salzburg · Medical University of Vienna, Vienna
Registry updated 2026-02-25
NCT06112314
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Trial Treatment · Phase 3 · Immunocore Ltd
Lkh - Universitaetsklinikum Graz, Graz · Universitätsklinikum St. Pölten, Pölten · Paracelsus Medizinischen Privatuniversitaet - SALK - Universitaetsklinik fuer Dermatologie - EB-Haus Austria, Salzburg · AKH - Medizinische Universitat Wien, Vienna
Registry updated 2026-02-25
NCT05733728
Retrospective Register for Uveal Melanoma
Research · Medical University of Vienna
Medical University of Vienna, Vienna
Registry updated 2023-05-06
NCT04045691
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Research · Pierre Fabre Pharma GmbH
11, Graz · 13, Innsbruck · 14, Klagenfurt · 10, Linz · 3, Linz · 12, Salzburg · 22, Vienna · 53, Vienna · 23, Wiener Neustadt
Registry updated 2021-01-19

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error